Indivior Pharmaceuticals, Inc. INDV Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's other noncash income (expense)?
- Indivior Pharmaceuticals, Inc. (INDV) reported other noncash income (expense) of $0 in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's other noncash income (expense) changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's other noncash income (expense) increased by 100.0% year-over-year, from -$1M to $0.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.